The role of ambulatory BP monitoring in clinical care

Geriatrics

Volumn 62, Issue 8, 2007, Pages 11-14

  Ommen, Elizabeth S ^a   Lipkowitz, Michael S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory blood pressure; Cardiovascular disease; Hypertension; Office blood pressure; White coat hypertension

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GERIATRIC CARE; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; PROGNOSIS; REVIEW; RISK REDUCTION; WHITE COAT HYPERTENSION;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIAGNOSTIC ERRORS; GERIATRIC ASSESSMENT; HUMANS; HYPERTENSION; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT;

EID: 34548160170     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407-2415.
2. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46(1):156-161.
3. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282(6):539-546.
4. Palatini P, Mormino P, Santonastaso M, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension. 1998;31(1):57-63.
5. Blanco F, Gil P, Arco CD, et al. Association of clinic and ambulatory blood pressure with vascular damage in the elderly: the EPICARDIAN study. Blood Press Monit. 2006;11(6):329-335.
6. Staessen JA, O'Brien ET, Atkins N, et al. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. The Ad-Hoc Working Group. J Hypertens. 1993;11(11):1289-1297.
7. Wiinberg N, Hoegholm A, Christensen HR, et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens. 1995;8(10 pt 1):978-986.
8. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9(1):1-11.
9. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259(2):225-228.
10. Dolan E, Stanton A, Atkins N, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004;9(6):307-309.
11. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-515.
12. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793-801.
13. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104(12):1385-1392.
14. Grandi AM, Broggi R, Colombo S, et al. Left ventricular changes in isolated office hypertension: a blood pressure-matched comparison with normotension and sustained hypertension. Arch Intern Med. 2001;161(22):2677-2681.
15. Moser M. White-coat hypertension - to treat or not to treat: a clinical dilemma. Arch Intern Med. 2001;161(22):2655-2656.
16. Fagard RH, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102(10):1139-1144.
17. Grandi AM, Solbiati F, Laurita E, et al. Isolated office hypertension: a 3-year follow-up study. Blood Press. 2005;14(5):298-305.
18. Palatini P. Masked hypertension: how can the condition be detected? Blood Press Monit. 2004;9(6):297-299.
19. Hansen TW, Jeppesen J, Rasmussen S, et al. Ambulatory blood pressure and mortality: a population-based study. Hypertension. 2005;45(4):499-504.
20. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131(8):564-572.
21. Bjorklund K, Lind L, Zethelius B, et al. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107(9):1297-1302.
22. Banegas JR, Segura J, Sobrino J, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49(1):62-68.
23. Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18(11):1422-1428.
24. Verdecchia P, Reboldi G, Porcellati C, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol. 2002;39(5):878-885.
25. Staessen JA, Bieniaszewski L, O'Brien E, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The 'Ad Hoc' Working Group. Hypertension. 1997;29(1 pt 1):30-39.
26. Pickering TG, Kario K. Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens. 2001;10(5):611-616.
27. Davidson MB, Hix JK, Vidt DG, et al. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006;166(8):846-852.
28. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347(11):797-805.
29. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20(11):2183-2189.
30. Hermida RC, Calvo C, Ayala DE, et al. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 2005;46(4):960-968.
31. Ernst ME, Bergus GR. Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey. BMC Fam Pract. 2003;4:15.
32. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5):846-853.
33. Bobrie G, Delonca J, Moulin C, et al. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations. Am J Hypertens. 2005;18(11):1482-1488.
34. Bayo J, Cos FX, Roca C, et al. Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension. Blood Press Monit. 2006;11(2):47-52.
35. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension. 2006;47(1):29-34.